title: Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.
authors.forename: M
authors.initials: M
authors.lastname: Nakagawa
authors.forename: N
authors.initials: N
authors.lastname: Watanabe
authors.forename: M
authors.initials: M
authors.lastname: Okuno
authors.forename: M
authors.initials: M
authors.lastname: Kondo
authors.forename: H
authors.initials: H
authors.lastname: Okagawa
authors.forename: T
authors.initials: T
authors.lastname: Taga
mesh_terms: D000208:Acute Disease; D000743:Anemia, Hemolytic / Q000276:immunology*; D015551:Autoimmunity; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D016756:Immunoglobulins, Intravenous